AH Capital Management’s Scribe Therapeutics SCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.7M Buy
+3,082,725
New +$81.3M 0.29% 8

Other funds holding SCTX

AH Capital Management's SCTX Position: Q3 2026 in Review

AH Capital Management opened a new position in Scribe Therapeutics (SCTX) in Q3 2026: 3,082,725 shares worth $56.7M. The stake represents 0.29% of the portfolio and ranks #8 among its holdings.

62 funds tracked by Wall St. Rank hold SCTX as of Q3 2026.

  • AH Capital Management held 3,082,725 shares of Scribe Therapeutics worth $56.7M as of Q3 2026.
  • Scribe Therapeutics was a new AH Capital Management position in Q3 2026.
  • Scribe Therapeutics made up 0.29% of AH Capital Management's portfolio in Q3 2026, its #8 holding.
  • 62 funds tracked by Wall St. Rank held Scribe Therapeutics as of Q3 2026.

Based on AH Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.